These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15884749)

  • 1. Introducing hepatitis B virus vaccine into the Expanded Programme on Immunization in Bangladesh: a proposed method to evaluate whether the existing infrastructure has the capacity.
    Trama A; Walker D; Fox-Rushby J
    J Health Popul Nutr; 2005 Mar; 23(1):25-33. PubMed ID: 15884749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa.
    Edmunds W; Dejene A; Mekonnen Y; Haile M; Alemnu W; Nokes D
    Health Policy Plan; 2000 Dec; 15(4):408-16. PubMed ID: 11124244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake.
    Suckling RM; Taegtmeyer M; Nguku PM; Al-Abri SS; Kibaru J; Chakaya JM; Tukei PM; Gilks CF
    J Hosp Infect; 2006 Nov; 64(3):271-7. PubMed ID: 16926061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
    Griffiths UK; Korczak VS; Ayalew D; Yigzaw A
    Vaccine; 2009 Feb; 27(9):1426-32. PubMed ID: 19146901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E; Mahon BE; Wang S; Woods ER
    J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
    Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia.
    Levin CE; Nelson CM; Widjaya A; Moniaga V; Anwar C
    Bull World Health Organ; 2005 Jun; 83(6):456-61. PubMed ID: 15976897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the efficacy of the national immunization programme for hepatitis B.
    Rubin L; Hefer E; Dubnov Y; Warman S; Rishpon S
    Public Health; 2007 Jul; 121(7):529-33. PubMed ID: 17320126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is universal better than selective immunization in developing world? Vaccines (HBV).
    Boyles S
    Hepatitis Wkly; 1998 Oct; ():7-8. PubMed ID: 12294767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination coverage survey in Dhaka District.
    Khan MN; Rahman ML; Awal Miah A; Islam MS; Musa SA; Tofail F
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):46-53. PubMed ID: 16967809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinating adolescents in high-risk settings: lessons learned from experiences with hepatitis B vaccine.
    Sneller VP; Fishbein DB; Weinbaum CM; Lombard A; Murray P; McLaurin JA; Friedman L;
    Pediatrics; 2008 Jan; 121 Suppl 1():S55-62. PubMed ID: 18174322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing the birth dose of hepatitis B vaccine in rural Indonesia.
    Creati M; Saleh A; Ruff TA; Stewart T; Otto B; Sutanto A; Clements CJ
    Vaccine; 2007 Aug; 25(32):5985-93. PubMed ID: 17604881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using lot quality assurance sampling to improve immunization coverage in Bangladesh.
    Tawfik Y; Hoque S; Siddiqi M
    Bull World Health Organ; 2001; 79(6):501-5. PubMed ID: 11436470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the control of hepatitis B infection in the Western Pacific Region.
    Clements CJ; Baoping Y; Crouch A; Hipgrave D; Mansoor O; Nelson CB; Treleaven S; van Konkelenberg R; Wiersma S
    Vaccine; 2006 Mar; 24(12):1975-82. PubMed ID: 16361001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power cuts and EPI vaccine storage.
    Senanayake MP; Perera AS; De Silva TU
    Ceylon Med J; 1997 Jun; 42(2):69-71. PubMed ID: 9257464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.